Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New HIV Drugs in Development, 2005.

Jeffrey P Nadler1, Michael C Phillips

  • 1Tampa General Hospital, Department of Infectious Diseases, G318, 2 Columbia Drive, Tampa, FL 33606, USA. jnadler@hsc.usf.edu.

Current Infectious Disease Reports
|April 26, 2005
PubMed
Summary

New human immunodeficiency virus (HIV) therapies are needed to overcome current treatment challenges. This review discusses promising new drugs in clinical trials to improve efficacy and reduce side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ABCA1-Mediated Structural Diversity of HDL Subspecies and Their Proposed Roles in Cardioprotection.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Surgical microwave ablation of 3035 liver tumors in 1416 patients: a retrospective analysis of 16 years of experience.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2025
Same author

Deep metabolic phenotyping of humans with protein-altering variants in <i>TM6SF2</i> using a genome-first approach.

JHEP reports : innovation in hepatology·2024
Same author

Analysis of technical failure after 1,613 surgical microwave ablations: A propensity score-matched analysis.

Surgery·2024
Same author

The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLD.

Med (New York, N.Y.)·2024
Same author

Outcomes after Surgical Microwave Ablation for the Treatment of Colorectal Liver Metastasis.

Journal of the American College of Surgeons·2024

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacology

Background:

  • The treatment of human immunodeficiency virus (HIV) has advanced significantly since the introduction of zidovudine.
  • Current highly active antiretroviral therapies (HAART) effectively target HIV but present challenges including adverse effects and the development of antiviral resistance.
  • There is an ongoing need for novel therapeutic agents with improved safety profiles, long-term efficacy, and activity against resistant viral strains.

Purpose of the Study:

  • To review the clinical needs in current HIV treatment.
  • To discuss new antiviral drugs currently in the clinical trial pipeline.
  • To highlight agents that may offer reduced adverse effects, long-term activity, and improved adherence.

Main Methods:

  • Literature review of current HIV treatment landscape.
  • Analysis of drugs in the clinical trial pipeline for HIV.
  • Discussion of emerging therapeutic strategies and their potential benefits.

Main Results:

  • Several new drugs targeting HIV are progressing through clinical trials.
  • These novel agents aim to address limitations of existing therapies, including adverse effects and drug resistance.
  • The development pipeline includes drugs with potential for enhanced convenience and adherence.

Conclusions:

  • Continued innovation in HIV drug development is crucial to address unmet clinical needs.
  • Newer agents in development show promise for improving patient outcomes and simplifying treatment regimens.
  • The pipeline of novel HIV therapeutics offers hope for more effective and tolerable long-term management of the infection.

Related Experiment Videos